Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Cilostazol in Moderate to Severe Ischemic Stroke
NCT06561867Phase 3Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Aug 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in ischemic stroke, sponsored by Kafrelsheikh University. Started Aug 2024; status: recruiting.
02
Drugs
ticagrelor
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06561867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06561867.